Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Exelixis Drug Fails Pivotal Prostate Cancer Study; Laying Off 70% of Employees
Exelixis Drug Fails Pivotal Prostate Cancer Study; Laying Off 70% of Employees
Exelixis Drug Fails Pivotal Prostate Cancer Study; Laying Off 70% of Employees
Submitted by
admin
on September 2, 2014 - 7:53am
Source:
TheStreet.com
News Tags:
Exelixis
prostate cancer
cabozantinib
layoffs
Headline:
Exelixis Drug Fails Pivotal Prostate Cancer Study; Laying Off 70% of Employees
Do Not Allow Advertisers to Use My Personal information
